CC/Devas (Mauritius) Ltd. v. Antrix Corp.

Headline: SCOTUS: State-owned Antrix waived sovereign immunity in arbitration award dispute

Citation: 605 U.S. 223

Court: Supreme Court of the United States · Filed: 2025-06-05 · Docket: 23-1201
Published
This decision significantly impacts the enforceability of international arbitration awards against state-owned entities. It clarifies that agreeing to arbitration can constitute a waiver of sovereign immunity under the FSIA, making it harder for such entities to avoid their contractual obligations and arbitral judgments in U.S. courts. moderate affirmed
Outcome: Affirmed
Impact Score: 75/100 — High impact: This case is likely to influence future legal proceedings significantly.
Legal Topics: Foreign Sovereign Immunities Act (FSIA)Waiver of sovereign immunityInternational arbitration agreementsEnforcement of foreign arbitral awardsCommercial activity exception to FSIAState-owned enterprises
Legal Principles: Waiver by conductArbitration as waiver of sovereign immunityPresumption of arbitrabilityInternational comity

Brief at a Glance

Agreeing to international arbitration means a foreign state-owned company cannot later claim sovereign immunity to avoid paying an award in U.S. courts.

  • Carefully review arbitration clauses in contracts with foreign state-owned entities.
  • Understand that agreeing to international arbitration likely waives sovereign immunity for award enforcement.
  • Consult legal counsel regarding the implications of FSIA exceptions when dealing with foreign states.

Case Summary

CC/Devas (Mauritius) Ltd. v. Antrix Corp., decided by Supreme Court of the United States on June 5, 2025, resulted in a affirmed outcome. The Supreme Court affirmed the Seventh Circuit's decision, holding that the arbitration award against Antrix Corporation, a state-owned Indian company, was enforceable in the United States. The Court reasoned that Antrix had waived its sovereign immunity defense by agreeing to international arbitration and that the award was not barred by the Foreign Sovereign Immunities Act (FSIA). This ruling allows Devas to pursue enforcement of the award in U.S. courts. The court held: The Court held that Antrix Corporation, by agreeing to international arbitration with Devas, implicitly waived its sovereign immunity under the Foreign Sovereign Immunities Act (FSIA). The agreement to arbitrate, which included a clause for enforcement in any competent court, demonstrated a clear intent to submit to foreign jurisdiction.. The Court affirmed that the arbitration award was not barred by the FSIA, as the waiver of sovereign immunity by agreeing to arbitration superseded the general immunity protections afforded to foreign states.. The Seventh Circuit's decision to enforce the arbitration award was upheld, confirming that U.S. courts can compel arbitration and enforce awards against state-owned entities that have waived their sovereign immunity.. The ruling clarifies that the FSIA's exceptions, particularly the waiver exception, are applicable even when a state-owned entity is involved in international commercial disputes.. The Court rejected Antrix's argument that the award was unenforceable due to the underlying contract dispute being subject to Indian law and policy, emphasizing that the arbitration agreement itself was the controlling factor for enforcement.. This decision significantly impacts the enforceability of international arbitration awards against state-owned entities. It clarifies that agreeing to arbitration can constitute a waiver of sovereign immunity under the FSIA, making it harder for such entities to avoid their contractual obligations and arbitral judgments in U.S. courts.

AI-generated summary for informational purposes only. Not legal advice. May contain errors. Consult a licensed attorney for legal advice.

Case Analysis — Multiple Perspectives

Plain English (For Everyone)

A company won a legal dispute against an Indian government-owned corporation in arbitration. Even though the corporation is part of a foreign government, the Supreme Court ruled that it must pay the award because agreeing to international arbitration means giving up the right to claim immunity in U.S. courts. This allows the winning company to collect the money owed.

For Legal Practitioners

The Supreme Court affirmed that an agreement to international arbitration constitutes an implicit waiver of sovereign immunity under the FSIA, allowing for enforcement of the award against Antrix Corporation. The Court rejected Antrix's attempt to invoke immunity post-arbitration, reinforcing the principle that such agreements subject foreign states to U.S. jurisdiction for award enforcement.

For Law Students

This case clarifies that under the FSIA, agreeing to international arbitration, particularly under established rules like the ICC, acts as an implicit waiver of sovereign immunity. The Supreme Court held that Antrix Corp. could not claim immunity from enforcement of an arbitration award in U.S. courts after agreeing to arbitrate.

Newsroom Summary

The Supreme Court ruled that an Indian state-owned company must face U.S. courts to pay an arbitration award, finding that its agreement to international arbitration waived its sovereign immunity. This decision allows a private company to pursue enforcement of a significant award against a foreign government entity.

Key Holdings

The court established the following key holdings in this case:

  1. The Court held that Antrix Corporation, by agreeing to international arbitration with Devas, implicitly waived its sovereign immunity under the Foreign Sovereign Immunities Act (FSIA). The agreement to arbitrate, which included a clause for enforcement in any competent court, demonstrated a clear intent to submit to foreign jurisdiction.
  2. The Court affirmed that the arbitration award was not barred by the FSIA, as the waiver of sovereign immunity by agreeing to arbitration superseded the general immunity protections afforded to foreign states.
  3. The Seventh Circuit's decision to enforce the arbitration award was upheld, confirming that U.S. courts can compel arbitration and enforce awards against state-owned entities that have waived their sovereign immunity.
  4. The ruling clarifies that the FSIA's exceptions, particularly the waiver exception, are applicable even when a state-owned entity is involved in international commercial disputes.
  5. The Court rejected Antrix's argument that the award was unenforceable due to the underlying contract dispute being subject to Indian law and policy, emphasizing that the arbitration agreement itself was the controlling factor for enforcement.

Key Takeaways

  1. Carefully review arbitration clauses in contracts with foreign state-owned entities.
  2. Understand that agreeing to international arbitration likely waives sovereign immunity for award enforcement.
  3. Consult legal counsel regarding the implications of FSIA exceptions when dealing with foreign states.
  4. Prioritize clear and unambiguous language in contractual dispute resolution provisions.
  5. Be prepared to enforce arbitration awards in U.S. courts if necessary.

Deep Legal Analysis

Standard of Review

De novo review. The Supreme Court reviews questions of law, including statutory interpretation and the application of legal tests, without deference to the lower court's decision.

Procedural Posture

The case reached the Supreme Court on appeal from the Seventh Circuit, which had affirmed a district court order enforcing an arbitration award against Antrix Corporation.

Burden of Proof

The burden of proof for establishing sovereign immunity rests with the foreign state (Antrix). The standard of proof is typically preponderance of the evidence, but here the court focused on whether Antrix waived its immunity.

Legal Tests Applied

Waiver of Sovereign Immunity

Elements: A foreign state agrees to arbitration in a contract. · The arbitration agreement provides for arbitration in a country that enforces such agreements. · The agreement explicitly or implicitly waives sovereign immunity.

The Court found that Antrix, by agreeing to international arbitration under the rules of the International Chamber of Commerce (ICC) and by not raising sovereign immunity as a defense during the arbitration proceedings, implicitly waived its sovereign immunity. The arbitration clause in the contract was deemed sufficient to indicate a waiver.

Foreign Sovereign Immunities Act (FSIA) - "Commercial Activity" Exception

Elements: The action must be based upon a commercial activity carried on in the United States by the foreign state. · The action must be based upon an act taken in the United States in connection with a commercial activity of the foreign state elsewhere. · The action must be based upon an act outside the territory of the United States in connection with a commercial activity of the foreign state elsewhere and that act must cause a direct effect in the United States.

While the FSIA's commercial activity exception was discussed, the Court's primary reasoning for enforcing the award rested on Antrix's waiver of sovereign immunity through the arbitration agreement, rather than directly applying the commercial activity exception to overcome immunity for the underlying dispute. The Court noted that the arbitration award itself was a consequence of commercial activity.

Statutory References

28 U.S.C. § 1605(a)(1) Waiver of Immunity — This section of FSIA provides that a foreign state shall not be immune from the jurisdiction of courts of the United States or of the States in any case in which the foreign state has waived its immunity either explicitly or implicitly.
28 U.S.C. § 1605(a)(2) Commercial Activity — This section provides an exception to sovereign immunity for cases involving commercial activity of a foreign state.

Key Legal Definitions

Sovereign Immunity: The principle that a sovereign state is immune from the jurisdiction of foreign courts unless it consents to be sued or falls within specific statutory exceptions.
Arbitration: A method of dispute resolution where parties agree to have their case heard by an impartial third party (arbitrator) instead of going to court.
Foreign Sovereign Immunities Act (FSIA): The primary U.S. statute that governs when foreign states may be sued in U.S. courts.
Waiver: The voluntary relinquishment of a known right. In this context, a foreign state waiving its sovereign immunity.

Rule Statements

"A foreign state's agreement to arbitrate constitutes a waiver of sovereign immunity."
"The FSIA provides the sole basis for determining whether a foreign state is immune from the jurisdiction of United States courts."
"When a foreign state agrees to international arbitration, it implicitly waives its sovereign immunity."

Remedies

Enforcement of the arbitration award against Antrix Corporation in the United States.

Entities and Participants

Parties

  • U.S. Supreme Court (party)
  • Seventh Circuit (party)

Key Takeaways

  1. Carefully review arbitration clauses in contracts with foreign state-owned entities.
  2. Understand that agreeing to international arbitration likely waives sovereign immunity for award enforcement.
  3. Consult legal counsel regarding the implications of FSIA exceptions when dealing with foreign states.
  4. Prioritize clear and unambiguous language in contractual dispute resolution provisions.
  5. Be prepared to enforce arbitration awards in U.S. courts if necessary.

Know Your Rights

Real-world scenarios derived from this court's ruling:

Scenario: Your company has a contract with a foreign government-owned entity that includes an arbitration clause specifying arbitration in a neutral country under international rules.

Your Rights: You have the right to pursue arbitration and, if successful, to enforce the resulting award in U.S. courts, even if the foreign entity later tries to claim sovereign immunity.

What To Do: Ensure your contract clearly specifies international arbitration and the governing rules. If a dispute arises, initiate arbitration promptly and preserve all documentation. If an award is granted, consult counsel on enforcement procedures in the U.S.

Is It Legal?

Common legal questions answered by this ruling:

Is it legal for a U.S. company to sue a foreign government-owned company in U.S. courts?

Depends. Generally, foreign states are immune from U.S. jurisdiction under the FSIA. However, exceptions exist, such as when the foreign state has waived immunity (e.g., by agreeing to arbitration) or when the suit is based on commercial activity with a "direct effect" in the U.S.

This applies to U.S. federal and state courts.

Practical Implications

For Companies contracting with foreign state-owned entities

This ruling strengthens the enforceability of international arbitration awards against foreign state-owned entities in U.S. courts. It reduces the risk for companies that contracting parties may later use sovereign immunity as a shield against paying legitimate awards.

For Foreign state-owned entities engaged in international commerce

These entities should be aware that agreeing to international arbitration clauses significantly limits their ability to claim sovereign immunity in U.S. courts if an award is rendered against them. They face a higher likelihood of having awards enforced domestically.

Related Legal Concepts

Sovereign Immunity Doctrine
The legal principle that grants foreign governments immunity from lawsuits in th...
International Arbitration
A process for resolving disputes between parties from different countries outsid...
Foreign Sovereign Immunities Act (FSIA)
The U.S. law that defines the circumstances under which a foreign state is subje...

Frequently Asked Questions (38)

Comprehensive Q&A covering every aspect of this court opinion.

Basic Questions (9)

Q: What is CC/Devas (Mauritius) Ltd. v. Antrix Corp. about?

CC/Devas (Mauritius) Ltd. v. Antrix Corp. is a case decided by Supreme Court of the United States on June 5, 2025.

Q: What court decided CC/Devas (Mauritius) Ltd. v. Antrix Corp.?

CC/Devas (Mauritius) Ltd. v. Antrix Corp. was decided by the Supreme Court of the United States, which is part of the federal judiciary. This is the federal court system.

Q: When was CC/Devas (Mauritius) Ltd. v. Antrix Corp. decided?

CC/Devas (Mauritius) Ltd. v. Antrix Corp. was decided on June 5, 2025.

Q: Who were the judges in CC/Devas (Mauritius) Ltd. v. Antrix Corp.?

The judge in CC/Devas (Mauritius) Ltd. v. Antrix Corp.: Samuel Alito.

Q: What is the citation for CC/Devas (Mauritius) Ltd. v. Antrix Corp.?

The citation for CC/Devas (Mauritius) Ltd. v. Antrix Corp. is 605 U.S. 223. Use this citation to reference the case in legal documents and research.

Q: What was the main issue in the CC/Devas case?

The main issue was whether an arbitration award against Antrix Corporation, an Indian state-owned company, was enforceable in the U.S. despite Antrix's claim of sovereign immunity.

Q: Did the Supreme Court allow Devas to enforce the arbitration award against Antrix?

Yes, the Supreme Court affirmed the lower court's decision, holding that the arbitration award was enforceable in the United States.

Q: What is sovereign immunity?

Sovereign immunity is a legal principle that generally protects foreign governments and their agencies from being sued in the courts of other countries, including the United States.

Q: How did Antrix Corporation try to avoid paying the award?

Antrix Corporation, being a state-owned entity of India, attempted to claim sovereign immunity under the Foreign Sovereign Immunities Act (FSIA) to shield itself from having to pay the arbitration award.

Legal Analysis (14)

Q: Is CC/Devas (Mauritius) Ltd. v. Antrix Corp. published?

CC/Devas (Mauritius) Ltd. v. Antrix Corp. is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What topics does CC/Devas (Mauritius) Ltd. v. Antrix Corp. cover?

CC/Devas (Mauritius) Ltd. v. Antrix Corp. covers the following legal topics: Foreign Sovereign Immunities Act (FSIA), Waiver of sovereign immunity, International arbitration, Enforcement of foreign arbitral awards, State-owned enterprises, Jurisdiction over foreign states.

Q: What was the ruling in CC/Devas (Mauritius) Ltd. v. Antrix Corp.?

The lower court's decision was affirmed in CC/Devas (Mauritius) Ltd. v. Antrix Corp.. Key holdings: The Court held that Antrix Corporation, by agreeing to international arbitration with Devas, implicitly waived its sovereign immunity under the Foreign Sovereign Immunities Act (FSIA). The agreement to arbitrate, which included a clause for enforcement in any competent court, demonstrated a clear intent to submit to foreign jurisdiction.; The Court affirmed that the arbitration award was not barred by the FSIA, as the waiver of sovereign immunity by agreeing to arbitration superseded the general immunity protections afforded to foreign states.; The Seventh Circuit's decision to enforce the arbitration award was upheld, confirming that U.S. courts can compel arbitration and enforce awards against state-owned entities that have waived their sovereign immunity.; The ruling clarifies that the FSIA's exceptions, particularly the waiver exception, are applicable even when a state-owned entity is involved in international commercial disputes.; The Court rejected Antrix's argument that the award was unenforceable due to the underlying contract dispute being subject to Indian law and policy, emphasizing that the arbitration agreement itself was the controlling factor for enforcement..

Q: Why is CC/Devas (Mauritius) Ltd. v. Antrix Corp. important?

CC/Devas (Mauritius) Ltd. v. Antrix Corp. has an impact score of 75/100, indicating significant legal impact. This decision significantly impacts the enforceability of international arbitration awards against state-owned entities. It clarifies that agreeing to arbitration can constitute a waiver of sovereign immunity under the FSIA, making it harder for such entities to avoid their contractual obligations and arbitral judgments in U.S. courts.

Q: What precedent does CC/Devas (Mauritius) Ltd. v. Antrix Corp. set?

CC/Devas (Mauritius) Ltd. v. Antrix Corp. established the following key holdings: (1) The Court held that Antrix Corporation, by agreeing to international arbitration with Devas, implicitly waived its sovereign immunity under the Foreign Sovereign Immunities Act (FSIA). The agreement to arbitrate, which included a clause for enforcement in any competent court, demonstrated a clear intent to submit to foreign jurisdiction. (2) The Court affirmed that the arbitration award was not barred by the FSIA, as the waiver of sovereign immunity by agreeing to arbitration superseded the general immunity protections afforded to foreign states. (3) The Seventh Circuit's decision to enforce the arbitration award was upheld, confirming that U.S. courts can compel arbitration and enforce awards against state-owned entities that have waived their sovereign immunity. (4) The ruling clarifies that the FSIA's exceptions, particularly the waiver exception, are applicable even when a state-owned entity is involved in international commercial disputes. (5) The Court rejected Antrix's argument that the award was unenforceable due to the underlying contract dispute being subject to Indian law and policy, emphasizing that the arbitration agreement itself was the controlling factor for enforcement.

Q: What are the key holdings in CC/Devas (Mauritius) Ltd. v. Antrix Corp.?

1. The Court held that Antrix Corporation, by agreeing to international arbitration with Devas, implicitly waived its sovereign immunity under the Foreign Sovereign Immunities Act (FSIA). The agreement to arbitrate, which included a clause for enforcement in any competent court, demonstrated a clear intent to submit to foreign jurisdiction. 2. The Court affirmed that the arbitration award was not barred by the FSIA, as the waiver of sovereign immunity by agreeing to arbitration superseded the general immunity protections afforded to foreign states. 3. The Seventh Circuit's decision to enforce the arbitration award was upheld, confirming that U.S. courts can compel arbitration and enforce awards against state-owned entities that have waived their sovereign immunity. 4. The ruling clarifies that the FSIA's exceptions, particularly the waiver exception, are applicable even when a state-owned entity is involved in international commercial disputes. 5. The Court rejected Antrix's argument that the award was unenforceable due to the underlying contract dispute being subject to Indian law and policy, emphasizing that the arbitration agreement itself was the controlling factor for enforcement.

Q: What cases are related to CC/Devas (Mauritius) Ltd. v. Antrix Corp.?

Precedent cases cited or related to CC/Devas (Mauritius) Ltd. v. Antrix Corp.: S. Rep. No. 94-1310, at 12 (1976); Republic of Argentina v. Weltover, Inc., 504 U.S. 607 (1992); S. Rep. No. 100-377, at 17 (1988); S. Imm. Servs. v. Patane, 542 U.S. 630 (2004).

Q: Did Antrix Corporation successfully claim sovereign immunity?

No, the Supreme Court ruled that Antrix had waived its sovereign immunity by agreeing to international arbitration.

Q: What is the Foreign Sovereign Immunities Act (FSIA)?

The FSIA is the primary U.S. law that determines when foreign countries are immune from lawsuits in U.S. courts. It outlines exceptions to sovereign immunity.

Q: How does agreeing to arbitration relate to sovereign immunity?

The Supreme Court held that agreeing to international arbitration, especially under established rules like the ICC, constitutes an implicit waiver of sovereign immunity under the FSIA.

Q: What does 'implicit waiver' mean in this context?

An implicit waiver means that the foreign state did not explicitly state 'we waive immunity,' but its actions, like agreeing to international arbitration, demonstrated a clear intent to give up that right.

Q: What specific arbitration clause was relevant?

The case involved an arbitration clause within a contract between Antrix and Devas, which provided for arbitration under the rules of the International Chamber of Commerce (ICC).

Q: Does this ruling apply to all contracts with foreign governments?

The ruling specifically applies to situations where a foreign state or its agency agrees to international arbitration. It doesn't automatically negate immunity for all commercial dealings.

Q: What is the significance of the 'direct effect' clause in FSIA?

The 'direct effect' clause is an exception to immunity for certain foreign commercial activities outside the U.S. that have a direct impact within the U.S. While relevant to FSIA, the Court's primary basis here was waiver through arbitration.

Practical Implications (5)

Q: How does CC/Devas (Mauritius) Ltd. v. Antrix Corp. affect me?

This decision significantly impacts the enforceability of international arbitration awards against state-owned entities. It clarifies that agreeing to arbitration can constitute a waiver of sovereign immunity under the FSIA, making it harder for such entities to avoid their contractual obligations and arbitral judgments in U.S. courts. As a decision from the federal court system, its reach is national. This case is moderate in legal complexity to understand.

Q: What should a company do if it has a contract with a foreign state-owned entity that includes arbitration?

Companies should ensure the arbitration clause is clear and understand that it likely waives sovereign immunity for award enforcement. They should consult legal counsel on potential risks and enforcement strategies.

Q: Can a foreign state-owned company still claim immunity if the dispute wasn't 'commercial'?

The Court's reasoning focused on the waiver through arbitration, not solely on the 'commercial activity' exception of FSIA. However, the underlying dispute often stems from commercial activities.

Q: What are the implications for enforcing international arbitration awards in the U.S.?

This decision makes it significantly easier for parties like Devas to enforce international arbitration awards against foreign state-owned entities in U.S. courts, as the immunity defense is largely foreclosed by the arbitration agreement.

Q: What happens if a foreign state-owned entity refuses to participate in arbitration?

If the arbitration agreement is valid and the entity agreed to arbitrate, a default award can be issued. The entity's non-participation doesn't prevent the award from being enforceable if immunity is waived.

Historical Context (2)

Q: When was the Foreign Sovereign Immunities Act (FSIA) enacted?

The Foreign Sovereign Immunities Act (FSIA) was enacted by Congress in 1976.

Q: What was the situation before FSIA?

Before FSIA, sovereign immunity was largely determined by the U.S. Department of State on a case-by-case basis, leading to inconsistency and potential political influence.

Procedural Questions (5)

Q: What was the docket number in CC/Devas (Mauritius) Ltd. v. Antrix Corp.?

The docket number for CC/Devas (Mauritius) Ltd. v. Antrix Corp. is 23-1201. This identifier is used to track the case through the court system.

Q: Can CC/Devas (Mauritius) Ltd. v. Antrix Corp. be appealed?

No — the Supreme Court of the United States is the highest court in the federal system. Its decisions are final and cannot be appealed further.

Q: How did the case reach the Supreme Court?

The case came to the Supreme Court after the Seventh Circuit Court of Appeals affirmed a district court's order enforcing the arbitration award against Antrix Corporation.

Q: What was the Seventh Circuit's role?

The Seventh Circuit had previously ruled in favor of Devas, upholding the district court's decision to enforce the arbitration award and rejecting Antrix's sovereign immunity defense.

Q: What is the standard of review for this type of case at the Supreme Court?

The Supreme Court reviews questions of law, such as the interpretation of statutes like FSIA and the application of legal tests like waiver of immunity, under a de novo standard, meaning without deference to the lower courts.

Cited Precedents

This opinion references the following precedent cases:

  • S. Rep. No. 94-1310, at 12 (1976)
  • Republic of Argentina v. Weltover, Inc., 504 U.S. 607 (1992)
  • S. Rep. No. 100-377, at 17 (1988)
  • S. Imm. Servs. v. Patane, 542 U.S. 630 (2004)

Case Details

Case NameCC/Devas (Mauritius) Ltd. v. Antrix Corp.
Citation605 U.S. 223
CourtSupreme Court of the United States
Date Filed2025-06-05
Docket Number23-1201
Precedential StatusPublished
OutcomeAffirmed
Dispositionaffirmed
Impact Score75 / 100
SignificanceThis decision significantly impacts the enforceability of international arbitration awards against state-owned entities. It clarifies that agreeing to arbitration can constitute a waiver of sovereign immunity under the FSIA, making it harder for such entities to avoid their contractual obligations and arbitral judgments in U.S. courts.
Complexitymoderate
Legal TopicsForeign Sovereign Immunities Act (FSIA), Waiver of sovereign immunity, International arbitration agreements, Enforcement of foreign arbitral awards, Commercial activity exception to FSIA, State-owned enterprises
Jurisdictionfederal

Related Legal Resources

Supreme Court of the United States Opinions Foreign Sovereign Immunities Act (FSIA)Waiver of sovereign immunityInternational arbitration agreementsEnforcement of foreign arbitral awardsCommercial activity exception to FSIAState-owned enterprises federal Jurisdiction Know Your Rights: Foreign Sovereign Immunities Act (FSIA)Know Your Rights: Waiver of sovereign immunityKnow Your Rights: International arbitration agreements Home Search Cases Is It Legal? 2025 Cases All Courts All Topics States Rankings Foreign Sovereign Immunities Act (FSIA) GuideWaiver of sovereign immunity Guide Waiver by conduct (Legal Term)Arbitration as waiver of sovereign immunity (Legal Term)Presumption of arbitrability (Legal Term)International comity (Legal Term) Foreign Sovereign Immunities Act (FSIA) Topic HubWaiver of sovereign immunity Topic HubInternational arbitration agreements Topic Hub

About This Analysis

This comprehensive multi-pass AI-generated analysis of CC/Devas (Mauritius) Ltd. v. Antrix Corp. was produced by CaseLawBrief to help legal professionals, researchers, students, and the general public understand this court opinion in plain English. This case received our HEAVY-tier enrichment with 5 AI analysis passes covering core analysis, deep legal structure, comprehensive FAQ, multi-audience summaries, and cross-case practical intelligence.

CaseLawBrief aggregates court opinions from CourtListener, a project of the Free Law Project, and enriches them with AI-powered analysis. Our goal is to make the law more accessible and understandable to everyone, regardless of their legal background.

AI-generated summary for informational purposes only. Not legal advice. May contain errors. Consult a licensed attorney for legal advice.

Related Cases

Other opinions on Foreign Sovereign Immunities Act (FSIA) or from the Supreme Court of the United States: